-
www.ahrq.gov/sites/default/files/publications/files/clabsifinal.pdf
October 01, 2012 - Eliminating CLABSI, A National Patient Safety Imperative: Final Report
Eliminating CLABSI,
A National Patient Safety
Imperative
Final Report on the National On the CUSP: Stop BSI Project
A Project of:
Health Research & Educational Trust
Johns Hopkins Medicine Armstrong Institute for Patient Safet…
-
www.ahrq.gov/sites/default/files/publications/files/impguide2.pdf
September 08, 2015 - The National Evaluation of the
CHIPRA Quality Demonstration Grant Program
Designing Care
Management Entities
for Youth with Complex
Behavioral Health Needs
Grace Anglin, Adam Swinburn, Leslie Foster, Cindy Brach, and Linda Bergofsky
Implementation Guide Number 2
2
Designing Care Management Entities for Youth w…
-
www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide2/implguide2pt4.html
September 01, 2014 - Designing Care Management Entities for Youth with Complex Behavioral Health Needs
Part 4: CME Design Features
Previous Page Next Page
Table of Contents
Designing Care Management Entities for Youth with Complex Behavioral Health Needs
Part 1: An Introduction to Care Management Entities (CMEs)
Par…
-
www.ahrq.gov/research/shuttered/acfselection/chapter4.html
July 01, 2018 - Disaster Alternate Care Facilities: Report and Interactive Tools
Chapter 4. Results
Previous Page Next Page
Table of Contents
Disaster Alternate Care Facilities: Report and Interactive Tools
Executive Summary
Chapter 1. Objectives
Chapter 2. Background
Chapter 3. Methods
Chapter 4. Results…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide1/impguide1.pdf
September 08, 2015 - Engaging Stakeholders to Improve the Quality of Children's Health Care
The National Evaluation of the
CHIPRA Quality Demonstration Grant Program
Engaging Stakeholders
to Improve the Quality of
Children’s Health Care
Ellen Albritton, Margo Edmunds, Veronica Thomas, Dana Petersen, Grace Ferry,
Cindy Brach, and …
-
www.ahrq.gov/hai/cauti-tools/archived-webinars/health-literacy-transcript.html
December 01, 2017 - Health Literacy and Patient and Family Engagement: Strategic Tools to Prevent CAUTI (July 9, 2013)
Webinar Transcript
Paul Tedrick
American Hospital Association – Chicago
July National Content Call
July 9, 2013
11:00 AM CT
Operator: The following is the July National Content Call for Paul Tedrick, …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/health-literacy-pfe-transcript.doc
July 09, 2013 - Paul Tedrick
Paul Tedrick
American Hospital Association – Chicago
July National Content Call
July 9, 2013
11:00AM CT
Operator:
The following is the July National Content Call for Paul Tedrick, with the American Hospital Association of Chicago on Tuesday, July 9, 2013 at 11:00 a.m. Central Time. Excuse me, everyone…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-intro-methods.pdf
September 01, 2019 - 2018 National Healthcare Quality and Disparities Report: Introduction and Methods
c2015 National Healthcare Quality and Disparities Report and National Quality Stategy 5th Anniversary Update
NATIONAL
HEALTHCARE
QUALITY &
DISPARITIES
REPORT
2018
Introduction
and Methods
This document is in the public doma…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/tearsheets/prenatalsp.html
October 01, 2014 - Usted puede dejar de fumar
Versión de texto
Recomendaciones y apoyo de su médico de cuidados prenatales
In English
Tanto para usted como para su bebé, ahora es buen momento para que deje de fumar
Tanto usted como su niño obtienen beneficios cuando deje de fumar. Los beneficios para los dos o para usted …
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide15.html
October 01, 2014 - 15. Development Process (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
A flow chart where the first topic flows into the second, and so on.
Panel reviewed updated evidence and made recommendations based on evidence.
Manuscript drafted and reviewed by…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide16.html
October 01, 2014 - 16. Development Process (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Topics for the update were solicited from the panel and public (about 100 topics suggested).
Literature searches conducted on about half of the topics.
Abstracts obtained.
A…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide34.html
October 01, 2014 - 34. What's New in 2008?
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
What's New in 2008?
Previous Slide Contents Next Slide
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide61.html
October 01, 2014 - 61. For the Patient Willing To Quit
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Strategy A1. Ask— Systematically identify all tobacco users at every visit
Action
Strategies for implementation
Implement an office wide system that ensures that, for E…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide62.html
October 01, 2014 - 62. For the Patient Willing To Quit (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Action
Strategies for implementation
In a clear, strong , and personalized manner, urge every tobacco user to quit.
Advice should be:
Clear —"It is …
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide63.html
October 01, 2014 - 63. For the Patient Willing To Quit (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Strategy A3. Assess —Determine willingness to make a quit attempt
Action
Strategies for implementation
Assess every tobacco user's willingness to make a qui…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide81.html
October 01, 2014 - 81. Treatment Recommendations: Counseling (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Meta-analysis (1996): Impact of having a tobacco use status identification system in place on abstinence rates among patients who smoke (n = 3 studies)
Screeni…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide94.html
October 01, 2014 - 94. Treatment Recommendations: Counseling (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Type of Clinician
Recommendation: Treatments delivered by multiple types of clinicians are more effective than interventions delivered by a single type of clinician…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide93.html
October 01, 2014 - 93. Treatment Recommendations: Counseling (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Type of Clinician
Recommendation: Treatment delivered by a variety of clinician types increases abstinence rates. Therefore, all clinicians should provide smoking c…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide95.html
October 01, 2014 - 95. Treatment Recommendations: Counseling (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Meta-analysis (2000): Effectiveness of and estimated abstinence rates for interventions delivered by different types of clinicians (n =29 studies)
Type of clin…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide145.html
October 01, 2014 - 145. Treatment Recommendations: Medications-Nicotine Patch
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Patient selection
Appropriate as a first-line medication for treating tobacco use
Precautions, warnings, contraindications and side effects (see FDA…